AUMsilence
Commercial- Indications
- Research use only
Company intelligence / Profile preview
AUM BioTech
Philadelphia, PA, USAaumbiotech.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Provides validated self-delivering antisense technologies enabling robust gene silencing in vitro and in vivo without transfection reagents. Widely adopted by academic and industry researchers globally for target validation and mechanistic studies across multiple biomedical fields.[2][3][4]
- Therapeutic areas
- OncologyImmunologyOtherNeurologyInfectious Diseases
- Modalities
- Antisense oligonucleotides (ASOs)Self-delivering antisense oligonucleotides (sdASO™)FANA ASOs (2'-deoxy-2'-fluoro-arabinonucleic acid antisense oligos)Exon skipping ASOs[4]Blocker oligos[4]Transfection-free gene silencing reagents[2][3][4]
- Industry
- Non-Drug Biotech
02
Drug pipeline
7 assets6 more assets in the full pipeline.
Request access →03
Partnerships
A joint initiative with AUM LifeTech (“Knockdown Coronavirus” program); no major pharma partnerships disclosed.[3]
Beyond the preview
Go deeper on AUM BioTech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AUM BioTech.